These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8505055)

  • 1. Protein-tyrosine kinases, oncogenes, and cancer.
    Parsons JT; Parsons SJ
    Important Adv Oncol; 1993; ():3-17. PubMed ID: 8505055
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncogenic kinase signalling.
    Blume-Jensen P; Hunter T
    Nature; 2001 May; 411(6835):355-65. PubMed ID: 11357143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth and differentiation control.
    Francis GE; Dómine M
    Cancer Chemother Biol Response Modif; 1992; 13():230-85. PubMed ID: 1389911
    [No Abstract]   [Full Text] [Related]  

  • 4. Dissecting oncogenes and tyrosine kinases in AML cells.
    Bianchi E; Rogge L
    MedGenMed; 2003 Jul; 5(3):10. PubMed ID: 14600647
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncogene signal transduction inhibitors from medicinal plants.
    Chang CJ; Ashendel CL; Geahlen RL; McLaughlin JL; Waters DJ
    In Vivo; 1996; 10(2):185-90. PubMed ID: 8744799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease.
    Scheijen B; Griffin JD
    Oncogene; 2002 May; 21(21):3314-33. PubMed ID: 12032772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The function of receptor protein tyrosine kinases: cell growth and more].
    Fujimoto J
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1477-83. PubMed ID: 9279071
    [No Abstract]   [Full Text] [Related]  

  • 8. The signaling and biological implications of FAK overexpression in cancer.
    Siesser PM; Hanks SK
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3233-7. PubMed ID: 16740741
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives.
    Kelloff GJ; Fay JR; Steele VE; Lubet RA; Boone CW; Crowell JA; Sigman CC
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):657-66. PubMed ID: 8824370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular cancer therapy using tyrosine kinase inhibitors].
    Lacotte-Thierry L; Guilhot F
    Rev Prat; 2002 Jan; 52(2):121-3. PubMed ID: 11915553
    [No Abstract]   [Full Text] [Related]  

  • 11. [Signal transduction by protein tyrosine kinases and antitumor agents].
    Mao YJ; Li HH; Li JF; Shen JS
    Yao Xue Xue Bao; 2008 Apr; 43(4):323-34. PubMed ID: 18664191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer biology: signatures guide drug choice.
    Downward J
    Nature; 2006 Jan; 439(7074):274-5. PubMed ID: 16421553
    [No Abstract]   [Full Text] [Related]  

  • 13. [Animal protein tyrosine kinases].
    Trojanek J
    Postepy Biochem; 2002; 48(1):66-73. PubMed ID: 12101526
    [No Abstract]   [Full Text] [Related]  

  • 14. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth.
    Di Domenico M; Castoria G; Bilancio A; Migliaccio A; Auricchio F
    Cancer Res; 1996 Oct; 56(19):4516-21. PubMed ID: 8813150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine kinase signalling pathways.
    Pawson T
    Princess Takamatsu Symp; 1994; 24():303-22. PubMed ID: 8983084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenes. Tricks with tyrosine kinases.
    Bishop JM
    Nature; 1986 Feb 27-Mar 5; 319(6056):722-3. PubMed ID: 3754033
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protein kinase inhibitors--screening of new molecular target therapeutics].
    Uehara Y
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):136-44. PubMed ID: 9030224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of signal transduction protein kinases as targets for cancer therapy.
    Mikalsen T; Gerits N; Moens U
    Biotechnol Annu Rev; 2006; 12():153-223. PubMed ID: 17045195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinases and gastric cancer.
    Lin W; Kao HW; Robinson D; Kung HJ; Wu CW; Chen HC
    Oncogene; 2000 Nov; 19(49):5680-9. PubMed ID: 11114748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: a new therapeutic strategy.
    Grant S; Jarvis WD
    Clin Cancer Res; 1996 Dec; 2(12):1915-20. PubMed ID: 9816149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.